MedTrace Logo

Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients

NCT03767569 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2018-12-06

No results posted yet for this study

Summary

A randomized controlled trial to evaluate whether pretreatment with myo-inositol can lower testosterone levels and improve clinical outcomes in hyperandrogenic PCOS patients undergoing ART

Conditions

  • PCOS
  • Female Infertility

Interventions

DRUG

Myo-inositol

Myo-inositol and Folic acid daily

DRUG

Folic Acid

Folic Acid daily

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03767569 on ClinicalTrials.gov